203 related articles for article (PubMed ID: 34283646)
1. Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer.
Mazzola R; Sicignano G; Cuccia F; Vitale C; Rigo M; Giaj-Levra N; Nicosia L; Figlia V; Ricchetti F; Attinà G; Pastorello E; De Simone A; Gurrera D; Naccarato S; Ruggieri R; Alongi F
Br J Radiol; 2021 Oct; 94(1126):20210521. PubMed ID: 34283646
[TBL] [Abstract][Full Text] [Related]
2. Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.
Cuccia F; Mazzola R; Nicosia L; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Vitale C; Mantoan B; De Simone A; Sicignano G; Ruggieri R; Cavalleri S; Alongi F
Radiat Oncol; 2020 Jul; 15(1):178. PubMed ID: 32698843
[TBL] [Abstract][Full Text] [Related]
3. Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes.
Alongi F; Rigo M; Figlia V; Cuccia F; Giaj-Levra N; Nicosia L; Ricchetti F; Vitale C; Sicignano G; De Simone A; Naccarato S; Ruggieri R; Mazzola R
Br J Radiol; 2021 Jan; 94(1117):20200848. PubMed ID: 33095659
[TBL] [Abstract][Full Text] [Related]
4. Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer.
Ruggieri R; Naccarato S; Stavrev P; Stavreva N; Fersino S; Giaj Levra N; Mazzola R; Mancosu P; Scorsetti M; Alongi F
Br J Radiol; 2015 Oct; 88(1054):20140736. PubMed ID: 26235142
[TBL] [Abstract][Full Text] [Related]
5. In regard to Cuccia et al.: impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.
Ghaffari H; Navaser M; Refahi S
Radiat Oncol; 2020 Aug; 15(1):199. PubMed ID: 32807168
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function.
Hwang ME; Mayeda M; Shaish H; Elliston CD; Spina CS; Wenske S; Deutsch I
Br J Radiol; 2021 Mar; 94(1119):20200433. PubMed ID: 33586999
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a rectal spacer with prostate SABR-first UK experience.
King RB; Osman SO; Fairmichael C; Irvine DM; Lyons CA; Ravi A; O'Sullivan JM; Hounsell AR; Mitchell DM; McGarry CK; Jain S
Br J Radiol; 2018 Feb; 91(1083):20170672. PubMed ID: 29182384
[TBL] [Abstract][Full Text] [Related]
8. Quantifying the impact of SpaceOAR hydrogel on inter-fractional rectal and bladder dose during 0.35 T MR-guided prostate adaptive radiotherapy.
Farjam R; Mahase SS; Chen SL; Coonce M; Pennell RT; Fecteau R; Chughtai B; Dewyngaert JK; Kang J; Ch Formenti S; Nagar H
J Appl Clin Med Phys; 2021 Sep; 22(9):49-58. PubMed ID: 34342134
[TBL] [Abstract][Full Text] [Related]
9. Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall.
Fischer-Valuck BW; Chundury A; Gay H; Bosch W; Michalski J
Pract Radiat Oncol; 2017; 7(3):195-202. PubMed ID: 28089528
[TBL] [Abstract][Full Text] [Related]
10. A comparison between hydrogel spacer and endorectal balloon: An analysis of intrafraction prostate motion during proton therapy.
Hedrick SG; Fagundes M; Robison B; Blakey M; Renegar J; Artz M; Schreuder N
J Appl Clin Med Phys; 2017 Mar; 18(2):106-112. PubMed ID: 28300377
[TBL] [Abstract][Full Text] [Related]
11. Functional imaging guided stereotactic ablative body radiotherapy (SABR) with focal dose escalation and bladder trigone sparing for intermediate and high-risk prostate cancer: study protocol for phase II safo trial.
Zapatero A; Castro P; Roch M; Carnero PR; Carroceda S; Rosciupchin AES; Hernández SH; Cogorno L; Iturriaga AG; García DB
Radiat Oncol; 2024 May; 19(1):54. PubMed ID: 38702761
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: A post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiotherapy.
Ma TM; Neylon J; Casado M; Sharma S; Sheng K; Low D; Yang Y; Steinberg ML; Lamb J; Cao M; Kishan AU
Radiother Oncol; 2022 Feb; 167():203-210. PubMed ID: 34979212
[TBL] [Abstract][Full Text] [Related]
13. A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy.
Hwang ME; Black PJ; Elliston CD; Wolthuis BA; Smith DR; Wu CC; Wenske S; Deutsch I
Radiat Oncol; 2018 Oct; 13(1):192. PubMed ID: 30285812
[TBL] [Abstract][Full Text] [Related]
14. A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes.
Song DY; Herfarth KK; Uhl M; Eble MJ; Pinkawa M; van Triest B; Kalisvaart R; Weber DC; Miralbell R; Deweese TL; Ford EC
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):81-7. PubMed ID: 23414766
[TBL] [Abstract][Full Text] [Related]
15. Seminal vesicle intrafraction motion during the delivery of radiotherapy sessions on a 1.5 T MR-Linac.
Muinck Keizer DM; Willigenburg T; der Voort van Zyp JRN; Raaymakers BW; Lagendijk JJW; Boer JCJ
Radiother Oncol; 2021 Sep; 162():162-169. PubMed ID: 34293410
[TBL] [Abstract][Full Text] [Related]
16. Comparison of rectal dose reduction by a hydrogel spacer among 3D conformal radiotherapy, volumetric-modulated arc therapy, helical tomotherapy, CyberKnife and proton therapy.
Saito M; Suzuki T; Sugama Y; Marino K; Sano N; Komiyama T; Aoki S; Maehata Y; Yoshizawa K; Ashizawa K; Suzuki H; Ueda K; Miyasaka Y; Araya M; Takahashi H; Onishi H
J Radiat Res; 2020 May; 61(3):487-493. PubMed ID: 32211861
[TBL] [Abstract][Full Text] [Related]
17. Long-term intra-fractional motion of the prostate using hydrogel spacer during Cyberknife® treatment for prostate cancer--a case report.
Sumila M; Mack A; Schneider U; Storelli F; Curschmann J; Gruber G
Radiat Oncol; 2014 Aug; 9():186. PubMed ID: 25142237
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trials.
Jones RT; Hassan Rezaeian N; Desai NB; Lotan Y; Jia X; Hannan R; Kim DWN; Hornberger B; Dubas J; Laine AM; Zelefsky MJ; Timmerman RD; Folkert MR
Med Dosim; 2017 Winter; 42(4):341-347. PubMed ID: 28774760
[TBL] [Abstract][Full Text] [Related]
19. [Dosimetric impact of hydrogel spacer use for stereotactic body radiotherapy of localised prostate cancer].
Ung M; Bossi A; Abbassi L; Vautier J; Anthonipillai V; Chevé M; Blanchard P
Cancer Radiother; 2021 May; 25(3):237-241. PubMed ID: 33419606
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison.
Ogita M; Yamashita H; Nozawa Y; Ozaki S; Sawayanagi S; Ohta T; Nakagawa K
Radiat Oncol; 2021 Jun; 16(1):107. PubMed ID: 34118956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
